The CEO of the diabetes clinic reviewed your recommendation on whether to continue with the disease management program based on your analysis of the pilot study that was the focus of Assignment 4.1. She indicated an appreciation for your work and said she was still evaluating your recommendation but wanted some additional input to help her make a final decision. She was unclear as to the purpose and meaning of the p-value that was reported in the results. She also was interested in your opinion on a research article she read on a different diabetes disease management program. The research reported that the distance patients had to travel to participate in the program had a negative effect on the success of the program. The research reported that this finding was statistically significant. The CEO was having trouble understanding what travel distance had to do with disease management and wanted your opinion on the interpretation of this finding. She was interested in knowing whether patient travel time should be included in your analysis (Assignment 4.1) as a factor of success.Prepare a brief memo (in lay terms) to the CEO of the diabetes clinic (Dr. Wilhelmina Smith) answering her questions about your analysis and the research report she read. Specifically, your memo should include the following:Discuss the p-value associated with the test statistic presented in the analysis in Assignment 4.1, explaining what the p-value means and how it should be interpreted in the context of evaluating the disease management program.Additionally, explain the meaning of statistical significance in the context of the research report your CEO mentioned regarding the relationship between travel time and the success of a disease management program. Answer her question regarding whether you should add patient travel time to your analysis of the success of your disease management program.